Investor FAQs
Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically-validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.
Mobia Medical, Inc.'s headquarters is located at 2802 Flintrock Trace, Suite 226, Austin, Texas 78738 and our telephone number is (855) 628-9375.
Mobia Medical, Inc. (formerly MicroTransponder, Inc.) was incorporated under the laws of State of Delaware in 2007. The Company changed its name to Mobia Medical, Inc. effective February 2026.
Effective February 24, 2026, MicroTransponder, Inc. changed its corporate name to Mobia Medical, Inc. The name of our product, Vivistim®, remains unchanged. For full details on the name change and what it means for the Company, please read our official press release here.
Mobia Medical, Inc.'s shares are traded on the Nasdaq exchange under the ticker symbol “MOBI”
Quarterly and annual reports, as well as other SEC filings, can be accessed on the SEC Filings portion of our Investor Relations website or directly from the SEC at www.sec.gov.
Our fiscal year end is December 31.
We do not intend to pay cash dividends on our common stock, as we intend to retain all available funds and any future earnings to support operations and finance the growth and development of our business.
Our independent registered public accountants are PricewaterhouseCoopers LLP.
Latham & Watkins LLP serves as our external legal counsel.
Equiniti Trust Company, LLC (“EQ”) serves as Mobia Medical’s Transfer Agent.
Equiniti Trust Company, LLC
EQ Shareowner Services
Attn: EQ Automated Scanning
1110 Centre Point Curve, Suite 101
Mendota Heights, MN
You can view our management team and members of our Board of Directors by visiting the About Us section of our website.
We will issue press releases that include the date of our quarterly earnings calls periodically. When the release is issued, call details and webcast links will be posted on the Events section of our website.
You can view our latest press releases, including our quarterly financial releases, on the News section of our website.
You can contact Mobia Medical, Inc.’s Investor Relations team via email at: investors@mobia.com
If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold shares in your name, you may reach our Transfer Agent, Equiniti Trust Company, at the address below or by visiting Equiniti’s Shareowner Online webpage.
Equiniti Trust Company, LLC
EQ Shareowner Services
Attn: EQ Automated Scanning
1110 Centre Point Curve, Suite 101
Mendota Heights, MN
For inclusion on the company’s distribution list, please fill out the email alerts page on our investor relations website.